Details of changes to the national screening system from 1 October, due to the closure of Public Health England.
NHS Sickle Cell and Thalassaemia Screening Programme
The Sickle Cell and Thalassaemia Screening Support Service in Oxford provides expert technical and scientific support to screening services.
The PHE sickle cell and thalassaemia (SCT) screening team is pleased to announce a new date for the very popular specialist counsellor update course – 8 December 2021. The course is delivered by King’s College London, funded by the national …
Changes to the newborn outcomes solution reflect feedback from users and include improvements for laboratory users and changes to data entry pages for laboratory and clinical (nurse/medical) users.
New national guidance published to support antenatal and newborn (ANNB) screening providers in addressing inequalities throughout the screening pathway.
Public Health England (PHE) has published the fourth set of quarterly 2020 to 2021 key performance indicator (KPI) data for the NHS screening programmes.
The newborn outcomes (NBO) solution is a web-based system for referring newborn babies who screen positive for sickle cell disease (SCD) and thalassaemia.
We are pleased to publish our third NHS antenatal screening standards data report.
The research advisory committee (RAC) reviews applications to carry out research involving NHS screening programme participants or requiring access to screening data or samples.
We (PHE Screening, and NHS England and NHS Improvement) want to take a moment to recognise the huge contribution of all staff who work so hard to deliver the NHS antenatal and newborn screening programmes.